文献速递牙周病

IL-1超家族成员与牙周疾病

IL-1 Superfamily Members and Periodontal Diseases.
PubMed 文献 · J Dent Res · 2020-08-06

本文综述IL-1超家族11个成员在牙周炎中的作用,包括激动剂、受体拮抗剂和抗炎细胞因子。IL-1Ra在防御牙周炎中起关键作用,IL-36可能调节黏膜炎症,IL-37和IL-38具抗炎特性但证据有限。靶向或促进特定细胞因子可能成为牙周炎新治疗策略。

要点

  • IL-1超家族含激动剂、受体拮抗剂和抗炎细胞因子,参与牙周炎炎症。
  • IL-1Ra是防御牙周炎的关键分子,IL-36可能调节黏膜炎症与稳态。
  • IL-37和IL-38具抗炎特性,但牙周炎中证据有限,治疗开发不足。

核心结论

  • IL-1超家族成员在牙周炎发病中起重要作用,靶向或促进特定细胞因子有望成为新治疗策略。

研究设计与样本

  • 综述,总结IL-1超家族成员的关键特性及其在牙周疾病中的作用。

主要发现

  • IL-1家族含11个成员:激动剂IL-1α、IL-1β、IL-18、IL-33、IL-36α、IL-36β、IL-36γ,受体拮抗剂IL-1Ra、IL-36Ra,抗炎细胞因子IL-37、IL-38。
  • IL-1Ra在防御牙周炎中起关键作用;IL-33主要诱导Th2相关细胞因子但作为警报素刺激肥大细胞。
  • IL-36亚类可能调节黏膜炎症与稳态;IL-37抑制固有和获得性免疫;IL-38具抗炎特性但通过不同受体。
  • IL-37和IL-38在牙周炎中证据有限;选择性IL-1家族成员治疗阻断仅在临床前和临床研究中部分探索。

临床怎么用

  • 关注IL-1Ra在牙周炎防御中的关键作用,以及IL-36对黏膜炎症的调节潜力。
  • IL-37和IL-38作为抗炎药物开发不足,需进一步研究其在牙周炎中的应用。

局限性

  • IL-37和IL-38在牙周炎中证据有限。
  • 选择性IL-1家族成员治疗阻断仅在临床前和临床研究中部分探索。
  • IL-37和IL-38作为抗炎药物的开发未充分考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Periodontitis is a complex, multifactorial chronic disease involving continuous interactions among bacteria, host immune/inflammatory responses, and modifying genetic and environmental factors. More than any other cytokine family, the interleukin (IL)-1 family includes key signaling molecules that trigger and perpetuate periodontal inflammation. Over the years, the IL-1 family expanded to include 11 members of cytokines, some with agonist activity (IL-1α, IL-1β, IL-18, IL-33, IL-36α, IL-36β, and IL-36γ), receptor antagonists (IL-1Ra, IL-36Ra), and 2 anti-inflammatory cytokines (IL-37, IL-38). The IL-1 receptor antagonist (IL-1Ra) has emerged as a pivotal player in the defense against periodontitis. IL-33 primarily induces the production of Th2-associated cytokines but acts as an "alarmin" via stimulation of mast cells. The IL-36 subclass of cytokines may be important in regulating mucosal inflammation and homeostasis. IL-37 suppresses innate and acquired immune responses. IL-38 is the most recent member of the IL-1 superfamily and has anti-inflammatory properties similar to those of IL-37 but through different receptors. However, limited evidence exists regarding the role of IL-37 and IL-38 in periodontitis. Despite the development of IL-1 blocking agents, therapeutic blockade of select IL-1 family members for periodontitis has only been partially investigated in preclinical and clinical research, while the development of IL-37 and IL-38 as novel anti-inflammatory drugs has not been considered adequately. Here, we review the key properties of the IL-1 family members and provide insights into targeting or promoting select cytokines as new therapeutic agents.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Papathanasiou E, Conti P, Carinci F, et al. IL-1 Superfamily Members and Periodontal Diseases. J Dent Res. 2020. PMID: 32758110. doi:10.1177/0022034520945209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。